Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the partnership, Grid will identify new antibody drug candidates for non-small cell lung cancer, by leveraging Infinimmune’s Anthrobody™ drug discovery platform.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Discovery PlatformProduct Type: Large molecule
Partner/Sponsor/Collaborator: Infinimmune
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership December 19, 2023
Details:
Infinimmune is reinventing antibody drug discovery by focusing solely on human-derived antibody drugs. Inside every human, the equivalent of 100 billion antibody clinical trials are conducted every day, testing each antibody for safety and efficacy in parallel.
Lead Product(s): Antibody
Therapeutic Area: Technology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Large molecule
Partner/Sponsor/Collaborator: Playground Global
Deal Size: $12.0 million Upfront Cash: Undisclosed
Deal Type: Financing December 07, 2022